Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Shares Outstanding (2020 - 2025)

BioAtla (BCAB) has 6 years of Shares Outstanding data on record, last reported at $58.8 million in Q3 2025.

  • For Q3 2025, Shares Outstanding rose 21.61% year-over-year to $58.8 million; the TTM value through Sep 2025 reached $58.8 million, up 21.61%, while the annual FY2024 figure was $58.1 million, 20.84% up from the prior year.
  • Shares Outstanding reached $58.8 million in Q3 2025 per BCAB's latest filing, roughly flat from $58.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $58.8 million in Q3 2025 and bottomed at $1.2 million in Q3 2022.
  • Average Shares Outstanding over 5 years is $38.2 million, with a median of $47.8 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: crashed 96.61% in 2022, then skyrocketed 3866.93% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $35.8 million in 2021, then plummeted by 96.61% to $1.2 million in 2022, then surged by 3866.93% to $48.1 million in 2023, then grew by 20.84% to $58.1 million in 2024, then increased by 1.19% to $58.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $58.8 million in Q3 2025, $58.7 million in Q2 2025, and $58.4 million in Q1 2025.